Copyright medicaldialogues
Ahmedabad: Zydus Lifesciences Limited has received NOC (Notice of Compliance) from Health Canada for generic Mesalamine suppositories 1000 mg.Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis. ZDS - Mesalamine suppositories will be manufactured at Zydus Lifesciences Ltd. Changodar, Ahmedabad in Gujarat, India. Mesalamine suppositories had annual sales of 4.86 mn CAD (Canadian Dollars) in Canada (IQVIA MAT June 2025). Read also: Zydus Gets CDSCO Panel Nod for Phase III Trial of Dextromethorphan, Phenylephrine Cough Syrup FDCEarlier in October, Zydus also received NOC from Health Canada for generic Liothyronine tablets 5 mcg and 25 mcg.Liothyronine tablets, a synthetic form of the thyroid hormone T3 (triiodothyronine), are primarily indicated for treating hypothyroidism.Read also: Zydus Lifesciences gets NOC from Health Canada for hypothyroidism tabletsZydus Lifesciences Ltd. is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group has a significant presence in cancer related therapies and offers a wide range of solutions with cytotoxic, supportive & targeted drugs.
